Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Good Start Genetics

Explore full profile

Tech platform to harness the power of NGS

Boston, United StatesFounded 2008Biotech & Life Sciences
Valuation $0–100M Latest valuation · 2012
Revenue $10–50M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Good Start Genetics and the history behind them.

About Good Start Genetics

Good Start Genetics, Inc. operated as a molecular diagnostics company with a focus on genetic testing services for inherited disorders, primarily within the reproductive health market. Founded in 2008 and headquartered in Cambridge, Massachusetts, the company aimed to establish a new standard of care for genetic screening by providing clinically relevant information to physicians and prospective parents. The company's founder was Gregory Porreca. Don Hardison, an executive with experience at companies like LabCorp and Exact Sciences, was appointed President and CEO in 2010.

Read full description

The company's business model revolved around providing advanced genetic testing services to a client base that included in vitro fertilization (IVF) clinics, obstetrician-gynecologist (Ob/Gyn) practices, and directly to consumers. Revenue was generated through the sale of these tests, which were often covered by insurance. The company pioneered the use of next-generation sequencing (NGS) in the reproductive health space, which allowed for a more simplified workflow and lower costs while maintaining high-quality results. Since its commercial launch in 2012, the company processed over 1.7 million tests.

Good Start Genetics developed a portfolio of products to address different stages of family planning. Its flagship in-clinic carrier screening service, GeneVu, offered a comprehensive menu of diagnostic tests for mutations causing inherited genetic disorders. For pre-implantation genetic screening, the company offered EmbryVu, which was based on technology licensed from Johns Hopkins University School of Medicine and designed for individuals using assisted reproduction. Recognizing the growing direct-to-consumer market, the company launched VeriYou, an at-home, physician-ordered carrier screening test that included genetic counseling and was available through Amazon. This multifaceted approach provided flexible and more affordable testing options for couples.

In a significant strategic move, Good Start Genetics was acquired by Invitae Corporation (NYSE: NVTA) in August 2017. The acquisition, valued at approximately $38.9 million, was part of Invitae's strategy to create a comprehensive genetic information platform covering all stages of life. The deal involved a combination of Invitae common stock and cash to retire Good Start's debt. Following the acquisition, Good Start Genetics became a wholly-owned subsidiary of Invitae, integrating its reproductive health testing services into Invitae's broader offerings. Keywords: genetic testing, molecular diagnostics, reproductive health, carrier screening, preimplantation genetic screening, next-generation sequencing, inherited disorders, IVF clinics, women's health, DNA sequencing, GeneVu, EmbryVu, VeriYou, genetic counseling, prenatal diagnosis, family planning, genetic information, inherited diseases, assisted reproduction, diagnostics services

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2008
Headquarters
Boston, United States
Employees
16
Open positions
None listed
Dealroom signal
71.2/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Testing, Risk Management, Biotechnology, DNA, Genetics and genomics, Spinout, Genome Engineering, Biotech and Pharma, medical testing, DT and LS, science-based
Client focus
b2b

Latest news

Press, funding announcements and product moves mentioning Good Start Genetics.

See all news

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONExit Jul 2017 $0 InVitae
DEBTDebt Dec 2016 $0 SV Health Investors
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022
2021
2020
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Good Start Genetics website traffic

Latest recorded traffic for Good Start Genetics is 790 monthly website visits, up 216% over the last three months. Good Start Genetics's team declined 11.1% over the past year.

Latest monthly visits790 3-month web change+216% 1-year team growth-11.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • OrbiMed
  • Safeguard Scientifics
  • SV Health Investors

Other known investors4 additional known investors

  • Harvard Medical School
  • Harvard University
  • InVitae
  • CRG
Team profiled 25 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Good Start Genetics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Good Start Genetics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.